A unified model for Duchenne muscular dystrophy gene involvement in cancer: context-dependent tumour suppression and

Lee Machado1, Leanne Jones1,2, Sonika Divakar1

  • 1Centre for Physical Activity and Life Sciences, University of Northampton, UK.

FEBS Open Bio
|August 20, 2025
PubMed

Insights

The Duchenne muscular dystrophy gene (DMD) has a dual role in cancer, acting as a tumor suppressor in aggressive cancers and an oncogene in less aggressive ones. This context-dependent function impacts patient survival outcomes across various tumor types.

Area of Science:

  • Oncology
  • Genetics
  • Molecular Biology

Background:

  • The Duchenne muscular dystrophy gene (DMD) is implicated in cancer development, but its precise role remains unclear.
  • Existing evidence on DMD's impact on cancer survival is inconsistent, necessitating further investigation.

Purpose of the Study:

  • To comprehensively analyze the global impact of DMD gene expression on survival outcomes across 33 distinct cancer types.
  • To elucidate the context-dependent role of DMD in tumorigenesis, differentiating between tumor suppressive and oncogenic functions.

Main Methods:

  • Utilized bulk RNA sequencing data from The Cancer Genome Atlas (TCGA) for global analysis.
  • Employed Kaplan-Meier analysis and Cox proportional hazard modeling to assess survival associations.
  • Conducted pathway analysis and hierarchical clustering to explore underlying mechanisms.

Main Results:

  • DMD expression significantly correlated with survival in nine cancer types (Bonferroni corrected, α=0.0015).
  • High DMD expression was associated with improved survival in some cancers and worsened outcomes in others.
  • The Duchenne muscular dystrophy gene (DMD) transcript Dp71ab mirrored total DMD trends, highlighting distinct tumor groups with opposing survival associations.

Conclusions:

  • DMD does not function uniformly as an oncogene or tumor suppressor across all cancers.
  • A context-dependent dual model is proposed: high DMD expression is tumor suppressive in aggressive cancers and oncogenic in less aggressive tumors.
  • Divergent effects of DMD may be linked to specific dystrophin-associated protein complex (DAPC) components involved in signaling and adhesion.

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.6K
Mouse Models of Cancer Study02:43

Mouse Models of Cancer Study

Mice have long served as models for studying human biology and pathology because of their phylogenetic and physiological similarity with humans. They are also easy to maintain and breed in the laboratory, and hence, many inbred strains are now available for research. Studies on mice have contributed immeasurably to our understanding of cancer biology.
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
5.7K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.9K
Satellite Stem Cells and Muscular Dystrophy01:21

Satellite Stem Cells and Muscular Dystrophy

Satellite stem cells or myosatellite cells are quiescent stem cells that Alexander Mauro first identified in 1961. These cells are located between the sarcolemma, the plasma membrane of muscle fibers, and the basal lamina, the connective tissue sheath covering it. These mononucleated cells are activated in response to muscle injury, can transform into myoblasts, and may form or repair muscle fibers. Myosatellite cells can provide additional myonuclei for muscle regeneration or return to a...
2.0K
Cancer-Critical Genes I: Proto-oncogenes01:33

Cancer-Critical Genes I: Proto-oncogenes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
9.1K
Cancers Originate from Somatic Mutations in a Single Cell02:21

Cancers Originate from Somatic Mutations in a Single Cell

Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
12.7K